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Background. Understanding the spatial dynamics of oral polio vaccine (OPV) transmission will improve resource targeting. 
Mexico provides a natural laboratory, as it uses inactivated polio vaccine routinely as well as OPV bi-annually.
Methods. Using geospatial maps, we measured the distance and density of OPV vaccinees’ shedding in the areas nearest to 
unvaccinated households in 3 Mexican villages. Comparison of transmission to unvaccinated households utilized a mixed effects 
logistic regression with random effects for household and time, adjusted for age, gender, area, and running water.
Results. The median distance from an unvaccinated household to its nearest OPV-shedding household was 85 meters (inter-
quartile range, 46–145) and the median number of vaccinees shedding OPV within 200 m was 3 (2–6). Transmission to unvaccinated 
households occurred by day 1. There was no association (odds ratio [OR] 1.04; 95% credible interval [CrI] 0.92–1.16) between the 
distance from OPV shedding and the odds of transmission. The number of OPV vaccinees shedding within 200 m came close to 
a significant association with unvaccinated transmission (OR 0.93; CrI 0.84–1.01), but this was not the case for households 100 or 
500 m apart. Results were consistent across the 3 villages.
Conclusions. Geospatial analysis did not predict community transmission from vaccinated to unvaccinated households, because 
OPV use resulted in rapid, low transmission levels. This finding supports the global cessation of OPV.
Keywords. cluster randomized trials; oral polio vaccine; polio; spatial.
The goal of global polio eradication may soon be reached. In 
2016, there were 37 cases of wild-type polio, a decrease from the 
87 cases in 2015 [1, 2]. Currently, only Pakistan and Afghanistan 
continue to have endemic transmission of wild-type serotype 1 
polio, and Nigeria reported 4 cases in September 2016 [2]. The 
success of the polio eradication effort can be largely attributed to 
the use of oral polio vaccine (OPV) in developing countries, due 
to its low cost, easy administration, and ability to confer passive 
immunization to contacts, presumably via fecal-oral infections. 
However, the risks from OPV use are now complicating eradica-
tion efforts. Vaccine-associated paralytic polio is a rare, adverse 
reaction to OPV administration, occurring in every 900 000 
doses [3]. Of more concern, prolonged circulation of OPV, pri-
marily in communities with suboptimal sanitation, can result in 
OPV mutation and neuroreversion, leading to circulating vac-
cine-derived poliovirus (cVDPV). In addition, cVDPVs studied 
in Nigeria were found to be as virulent as wild-type polio [3].
To date, the spatial characteristics of OPV transmission are 
not well characterized. Understanding the pattern and extent of 
geographic variation in OPV circulation could help to predict 
and prepare for the risk of OPV reintroduction, especially in 
undervaccinated communities. Areas of increased risk could be 
detected, and resources accordingly deployed to reduce or pre-
vent prolonged OPV circulation. In the current global setting of 
polio transmission, this is particularly important for serotype 
2, which was declared eradicated as of September 2015 by the 
World Health Organization [4].
In this study, we had the opportunity to identify household 
and community transmission of OPV in Mexico, where inacti-
vated polio vaccine (IPV) is provided for routine immunization 
at 2, 4, 6, and 18 months of age and OPV is only administered 
in 2 National Health Weeks (NHW) to children 5 years of age 
and under. We were able to investigate spatial transmission 
at a household level within 3 villages that received different 
levels of OPV vaccinations during the February 2015 NHW. 
Furthermore, we collected stool samples that allowed for the 
detection of OPV transmission from vaccinated children to 
their households and community contacts. Spatial analyses of 
polio transmission have been performed as far back as 1967 [5]; 
however, most involved aggregated case data over large areas of 
several kilometers [6–8]. This study allowed an investigation at 
a local level of what happens in a community when the OPV 
vaccine is introduced.
In this paper, we explore 2 aspects of between-household 
transmission of polio. First, we consider whether living near 
someone who is shedding poliovirus affects an individual’s 
chance of shedding poliovirus. Second, we determine how 
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the number of people shedding near an unvaccinated contact 
impacts that individual’s chance of acquiring and shedding 
poliovirus. We refer to the distance and density of shedding, 
collectively, as proximity to shedding.
METHODS
Study Design
The study has already been described in detail elsewhere [9] 
but, in brief, this was a prospective, cluster-randomized trial in 
3 indigenous localities in Orizaba, Veracruz, Mexico (Capoluca, 
Campo Grande, and Tuxpanguillo). Within each community, 
approximately 150 households were enrolled in this study, and 
each community cluster received a different amount of OPV 
coverage as part of the study: 70% of enrolled households in 
Capoluca, 30% in Campo Grande, and 10% in Tuxpanguillo. 
When enrollment began in February 2015, 155 households 
were randomized to receive OPV out of 466 households 
included across the 3 localities. No other households in any of 
the 3 communities received OPV until the May 2015 NHW. 
Only 1 child from each of the 155 households received OPV. 
Inclusion criteria for household enrollment was the presence 
of a child <5 years old who had an up-to-date IPV vaccination 
record and was eligible to receive OPV. All adult participants 
consented to participation, and the guardians of minors con-
sented for minors to participate. Exclusion criteria for children 
<5 included presentation with illness (febrile, diarrhea, or res-
piratory); an immunodeficiency caused by AIDS, disease, or 
medication; a recent blood transfusion; and prior adverse reac-
tions to OPV. Exclusion criteria for all other participants was 
refusal to participate or a change in residence during the study 
period. Within our study population, global positioning system 
(GPS) coordinates were collected from 423 households: 137 of 
the vaccinated households and 286 unvaccinated households. 
As a result, only the shedding and transmission results from 
these participants were considered in this analysis.
After enrollment, 10 stool samples were scheduled for collec-
tion from each member of all enrolled households: 1 baseline 
sample before vaccination and 1 sample each at 1, 4, 7, 10, 14, 21, 
28, 51, and 71 days after vaccination. During each visit, health 
information, travel and visit details, and records for any vaccines 
received during the study period for children <5 were collected 
via follow-up surveys. Exclusion criteria for follow up were indi-
viduals that refused to participate, changes in residence during 
the study period, or absence during follow-up visits.
Viral ribonucleic acid (RNA) was extracted from frozen stool 
samples utilizing the MagNA Lyser (Roche) and KingFisher 
Duo Prime (Fisher Scientific), using the bacteriophage MS2 
as an internal control for extraction efficiency. Viral RNA 
then underwent quantitative, reverse-transcription polymer-
ase chain reaction (rt-QPCR) in order to detect and quantify 
any Sabin OPV present in the samples. The probes and prim-
ers were adopted and adapted from Kilpatrick et  al. [10] and 
the Centers for Disease Control protocol for polio quantita-
tive-PCR. Samples were run in triplicate and a sample was con-
sidered positive if two-thirds of reactions had a cycle threshold 
(Ct) <37. Positive samples were re-run to minimize false posi-
tives and, if positive, the RNA was Sanger-sequenced again for 
confirmation.
Sample
We used 2 types of participants from the study: vaccinated 
individuals and individuals who lived in unvaccinated house-
holds, referred to here as unvaccinated individuals. We were 
interested in the outcomes of unvaccinated individuals and 
Figure 1. Spatial mapping of oral polio vaccine transmission shedding over time.
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their proximity to vaccinated individuals. Therefore, vacci-
nated participants were not analyzed directly; instead, we 
created spatial variables for unvaccinated participants by 
comparing the locations of vaccinated and unvaccinated 
households. For instance, we measured the distance from 
an unvaccinated person to their nearest vaccinated house-
hold. We did not include unvaccinated people who lived 
in vaccinated households, as the focus of our analyses was 
between-household transmission. Within-household trans-
mission is being analyzed separately [11]. Vaccinated indi-
viduals were treated as sources, because we could be more 
certain their shedding was due to the OPV and not transmis-
sion from other participants.
Descriptive Analyses
Maps were used to visualize the spatial distribution of vaccina-
tion and shedding. We represented the density and location of 
vaccinated shedding over time using contour plots and overlaid 
the position of unvaccinated participants.
The distributions of key variables were assessed graphically 
and through the calculation of summary statistics. Spatial vari-
ables were summarized using medians and interquartile ranges, 
as they were skewed. Coverage of the vaccine was considered 
important to adjust for, as higher coverage led to both a smaller 
distance to the nearest shedding household and a higher pro-
portion of shedding.
Statistical Analyses
Outcomes
Stool samples were collected from participants at 10 points in 
time. We only analyzed data from the first 28 days of the study, 
as almost all the shedding occurred before this point. We first 
looked at the presence of poliovirus in stool samples and the 
proximity of unvaccinated partipants to vaccinated partici-
pants’ shedding at any time point in the first 28 days. Second, 
we considered the presence of poliovirus and the proximity of 
households at each given point in time.
Spatial Variables
For the first analysis, the outcome was a binary variable for 
shedding at each point in time throughout the study period. We 
used a spatial variable approach, as identified in a recent sys-
tematic review [12]. The approach includes a covariate for spa-
tial proximity in a regression model and is similar to previous 
spatial analyses of mosquito bed-net trials [13, 14]. We meas-
ured each unvaccinated participant’s proximity to any vacci-
nated participant that was shedding, aggregated over the study 
period. Proximity was measured in 2 ways: the distance to the 
nearest vaccinated, shedding household and the number of vac-
cinated individuals shedding within 100, 200, 500, and 1000 m. 
Sensitivity analyses were performed, restricting the data to the 
first 14 days to reduce the risk of shedding being recorded due 
to secondary transmission.
For the second analyses, we calculated the same spatial varia-
bles, but within each point in time; therefore, the distance to the 
nearest vaccinated, shedding household could change depend-
ing on the study day. We also calculated the spatial variables 
using calendar days after initiation of the NHW OPV adminis-
tration, and found no differences in the outcomes. In addition 
to this, we examined whether the amount of the viral load sur-
rounding an unvaccinated household affected the likelihood of 
shedding. Here, we used the sum of the log viral load, where a 
greater number represents a higher viral load and a lower num-
ber a lower viral load.
Modelling
The study is a cluster-randomized trial with a hierarchical struc-
ture, giving multiple observations per individual per house-
hold. Mixed-effects logistic regression with a random effect 
for household was used to assess the association of the distance 
and density of vaccinated shedding with unvaccinated shed-
ding over the 28-day period. A mixed-effects logistic regression 
with a random effect for household and an autoregressive lag 1 
random effect for study day was used to look at the impact of 
the distance and density of OPV shedding and viral loads. The 
autoregressive random effect allows the previous study period 
to provide information to the next period. We adjusted for par-
ticipant age and gender and for access to running water within 
the household.
The spatial variables were included as continuous variables. 
Non-linearity was explored using quadratic terms and treat-
ing the variables as categorical; there was no suggestion of 
non-linear effects. The analyses were repeated by Sabin type: 
this increased the sparsity of the data and those results are not 
included, as they were consistent with the main analyses. The 
models were fitted using integrated, nested Laplace approxima-
tion, [15] and all analyses were performed using R [16]
RESULTS
Descriptive
There are 1145 unvaccinated individuals included in the anal-
yses, from 286 households. The age distribution was positively 
skewed, with a median age of 17 years and a range from 1 month 
to 95  years. Female participants made up 58.1% of the study. 
Further details, stratified by community, can be seen in Table 1. 
Unvaccinated individuals provided 10 059 stool samples in 
total: 978 (85.4%) people contributed 8 or more out of a possible 
10 samples and 57 (5.0%) individuals contributed only 1 sam-
ple. There was no missing data for the variables of age, running 
water in household, and gender, and the only missing data was 
the omission of stool samples. If we assume each participant 
could have provided 10 stool samples, then we observed 87.8% 
of the 11 450 potential samples for unvaccinated individuals.
In unvaccinated individuals, there were 89 (0.9%) positive 
samples, which came from 80 (7.0%) individuals; only 6 people 
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contributed more than 1 positive sample. The number of posi-
tive samples varied over time, with 24 positive samples observed 
at day 7, 2 at day 10, and 8 at day 14. More details at each point 
in time by locality can be found in the Supplementary Material.
In the original study, 155 children were vaccinated. Of these, 
137 (88.4%) had GPS data that was used to calculate the spatial 
variables; the remaining 18 did not have GPS data and were not 
used in the analyses, as we do not know their locations. The 
locations of the households, as well as the participants inter-
vention and outcome statuses, are displayed in Figure  1. The 
median distance to vaccinated households for unvaccinated 
individuals was 77.6 m (interquartile range 42.0 to 126.1 m). All 
unvaccinated households were within 826.4 m of a vaccinated 
household at some point in the study, and no household was 
closer to shedding in any village other than in their own.
The vaccinated children provided 1237 samples, of which 342 
(27.6%) were positive. There were 108 vaccinated children who 
shed OPV at any point in the study.
An analysis of the samples collected at baseline confirmed 
that no children <5 were shedding before the study began. 
Shedding began quickly, and between-household transmission 
occurred on the first study day in some cases. In addition, the 
vaccinated children tended to shed more consistently through-
out the study, with 36 (26.3%) individuals providing 4 or more 
positive samples and 2 individuals providing 8 positive stool 
samples. This can be seen in Figure  2, where the contours 
are present early on and are consistent throughout the study. 
Unvaccinated shedding occurred early in the study, but the 
location of shedding was more variable over time.
Spatial Variables
The median distance from unvaccinated participants to vacci-
nated, shedding participants during the first 28 days was 85.0 m 
(46.0 to 145.0 m), with a breakdown by village given in Figure 3. 
The median distance at any given time varied over the study 
period, ranging from 126.1 m on study day 4 to 1626.3 m on 
Figure 2. Maps of study areas.
Table 1. Characteristics of Unvaccinated Individuals by Coverage Area
Coverage Area
Total70% Vaccinated 30% Vaccinated 10% Vaccinated
Households with GPS, n 126 136 161 423
Vaccinated households, n 80 40 17 137
Unvaccinated households, n (%) (%) 46 (36.5%) 96 (70.6%) 144 (89.4%) 286 (67.6%)
Unvaccinated participants, n 161 396 588 1145
 Shedding, n (%) 24 (14.9%) 32 (8.1%) 24 (4.1%) 80 (7.0%)
 Age in years, median (IQR) 12.2 (4.0 to 27.0) 17.0 (4.0 to 30.2) 18.0 (4.2 to 33.0) 17.0 (4.1, 31.0)
 Female, n (%) 98 (60.9%) 223 (56.3%) 344 (58.5%) 665 (58.1%)
 Running water, n (%) 142 (88.2%) 343 (86.6%) 521 (88.6%) 1006 (87.9%)
 Samples provided, n 1294 3202 5563 10 059
 Positive samples, n (%) 30 (2.3%) 33 (1.0%) 26 (0.5%) 89 (0.9%)
Abbreviations: GPS, global positioning system; IQR, interquartile range.
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/article-abstract/67/suppl_1/S18/5146686 by London School of H
ygiene & Tropical M
edicine user on 01 N
ovem
ber 2018
S22 • CID 2018:67 (Suppl 1) • Jarvis et al
study day 71, when there were very few cases of vaccinated 
shedding (Figure 4). The median number of shedding individu-
als within 200 meters was 3 (2 to 6); further distances are shown 
in Table  1. There were no discernible patterns for proximity 
after stratifying by outcome and locality; these summary meas-
ures are presented in Table 2.
Models
After adjusting for age, gender, and access to running water, there 
was very little suggestion (odds ratio [OR] 1.15; 95% credible 
interval [CrI] 0.86–1.46) of an association between distance (per 
100 meters) from a vaccinated, shedding household and the odds 
of shedding for an unvaccinated individual. This was consistent 
when considering non-linear effects of distance. Incorporating 
time into the analysis with an autoregressive lag of 1 resulted in 
comparable results, with an OR of 1.04 (CrI 0.92–1.16). There 
was also no indication that the density of vaccinated household 
shedding within 200 m of an individual affected their odds of 
shedding (OR 0.99; CrI 0.95–1.04). When including time, there 
was some suggestion that the number of shedding, vaccinated 
individuals within 200  m may have had some effect on the 
shedding of unvaccinated individuals (OR 0.93; CrI 0.84–1.01). 
Results for other distances are displayed in Table 3. Restricting 
the analysis time to 14 days instead of 28 gave consistent results. 
The viral loads of individuals surrounding a person did not 
appear to have an association with the odds of shedding (results 
are presented in the Supplementary Material).
DISCUSSION
Through visualization of transmission onto maps, we were 
able to determine the dynamics of geospatial OPV transmis-
sion in a community with primary, IPV-induced immunity. 
We found that shedding due to the introduction of an oral 
polio vaccine (OPV) occurred rapidly and was associated with 
between-household transmission on the first day of OPV vac-
cination. We found little evidence to suggest that living nearer 
to a household with a person who was shedding OPV affected 
the likelihood of shedding OPV, up to the village dimensions of 
850 meters. Indeed, there were no statistical differences in OPV 
acquisition among unvaccinated individuals based on their dis-
tance from vaccinated individuals. In addition, the threshold 
for OPV dispersion appeared to be low: between-household 
Figure 3. Distance from nearest vaccinated shedding household for unvaccinated individuals.
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transmission in the 10% and 70% vaccination coverage com-
munities were similar and, therefore, only a small amount of 
OPV appeared to be needed for community transmission of 
OPV. This raises important implications regarding the impact 
of using OPV in future outbreaks and vaccination campaigns, 
especially as the transmission of OPV would usually be unde-
tected, at least in highly-vaccinated communities.
There are several strengths of this study. First, the study 
included a large amount of individual-level data, with multiple 
observations per person. To the authors’ knowledge, previous 
spatial analyses have only been conducted at an aggregated level 
on wild-type polio, where the detection of cases was not through 
stool samples. As no other children were vaccinated with OPV 
in these communities until May 2015, we know the precise 
sources of OPV in these communities during the study period, 
giving us insight into what happens when OPV is administered 
a single time. Second, we were also able to consider the impact 
of variation of coverage, as 3 separate villages had 10%, 30%, 
and 70% vaccinated cover of children. Third, as a requirement 
of the study was that all vaccinated children had up-to-date IPV 
vaccinations, this data mimics the transmission environment in 
future settings, as the Polio Endgame requires at least 1 dose of 
IPV in routine immunization schedules globally [2].
Using household location to represent a person’s location is, 
at best, an imprecise average of their movement throughout 
the day. Furthermore, it necessitates grouping people who live 
together to the same location. Information from contact tracing 
might have been useful to measure the proximity of individuals, 
but might not be available in practice. It seems clear that the 
transmission of polio is not purely spatial; when only house-
hold location is available, it appears to have a limited ability to 
predict transmission.
Table 2. Spatial Characteristics Comparing Unvaccinated Shedding with Unvaccinated Non-Shedding Individuals
Unvaccinated N
Distance to Nearest Vaccinated Number of Vaccinated Shedding Households Within:
Household Shedding Household 100 m 200 m 500 m 1000 m
70% Coverage Median (IQR)
Positive 24 42.5 (19.7, 69.6) 44.9 (28.7, 69.6) 2.5 (2, 5) 10 (7, 19) 54 (43, 61) 78 (77, 79)
No Shedding 137 41.8 (18.5, 57.7) 45 (27.5, 71) 3 (2, 5) 10 (8, 16) 58 (43, 62) 78 (77, 78)
30% Coverage
Positive 32 78.8 (53.6, 99.5) 83.5 (63.7, 124.1) 1 (1, 2) 6 (1.8, 8) 22.5 (16, 25.2) 38 (37, 39)
No Shedding 364 71.3 (37.9, 99.8) 82.4 (51.7, 130) 1 (1, 2) 5 (2, 8) 22 (13.8, 26) 38 (36, 39)
10% Coverage
Positive 24 115.7 (56.1, 209.4) 115.7 (57, 211.8) 0.5 (0, 1) 2 (0, 3) 6 (3.8, 10) 15 (12.2, 15)
No Shedding 564 99.7 (55.3, 150.2) 112.1 (56.1, 160.1) 1 (0, 1) 2 (1, 3) 8 (4, 10) 15 (14, 16)
All distances shown are in meters. 
Abbreviation: IQR, interquartile range.
Figure 4. Median distance from vaccinated shedding over time.
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We tried to minimize any misclassification of within-house-
hold transmission as between-household transmission by 
only using vaccinated individuals as point sources and unvac-
cinated households in the analyses. We excluded individuals 
who were unvaccinated and living with vaccinated individuals. 
Misclassification cannot be removed entirely, due to the prop-
agation of between- and within-household transmission. We 
also attempted to reduce the number of false positives for stool 
samples by using a 2-step laboratory process to identify OPV by 
RT-QPCR; however, it is likely that there were small numbers 
of false negative and false positive samples. However, given the 
large number of individuals and stool samples collected, it is 
unlikely that a small number of incorrectly-identified samples 
would have affected the conclusions of this paper.
Our results show that vaccinated children shed as early as 
1 day post-vaccination. This result is supported by prior OPV 
trials, where most vaccinated children shed within 1 week of 
vaccination [17–19]. That OPV can be transmitted to the con-
tacts of vaccinated children has also been well-documented in 
these trials. Low levels of transmission also occur as quickly 
as 1 week after vaccination, as shown by transmissibility trials 
from the 1960s, the results which are corroborated by more 
recent work in Zimbabwe looking at human immunodeficiency 
virus–infected mothers with OPV-vaccinated children [17–20]. 
However, these studies collected samples on a weekly basis. 
Our samples were collected with more granularity, and show 
that between-household transmission occurred within 1 day of 
vaccination, even in the community with 10% OPV coverage.
Household locations and spatial distribution appear to have 
limited use in predicting the transmission of poliovirus shedding. 
Therefore, in order to understand how OPV shedding occurs 
within a community, alternative information, such as contact pat-
terns, should be analyzed. The mechanism for predicting shed-
ding is not well understood, including the role of number of prior 
IPV and OPV doses and the viral loads seen after vaccination.
The use of a live poliovirus vaccine results in rapid dispersion 
and persistent transmission of the poliovirus throughout a com-
munity, up to at least 71 days. The only way to avoid this is to not 
use OPV or to have strong controls around those vaccinated, such 
as quarantine or strict hygiene protocols. At present, what we 
observed in this study would not be detected through any clinical 
screening, since all transmissions were asymptomatic and detected 
by the analyses of prospectively-collected stool samples. Therefore, 
better methods, such as the collection and analysis of sewage sam-
ples, are critically needed to ensure shedding has stopped within a 
community. Without this, any conclusions about the eradication 
of circulating polioviruses are overconfident at best. These results 
further support the Polio Eradication and Endgame Strategic Plan 
2013–2018’s intention to withdraw all OPV vaccines by 2020 [2]. 
After withdrawal of OPV, worldwide reintroduction due to an out-
break should be carefully considered, as it appears a small amount 
of OPV may result in community transmission.
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